Literature DB >> 32772573

Left Ventricular Mass Index Is Associated With Cognitive Function in Middle-Age: Bogalusa Heart Study.

Alexander C Razavi1,2, Camilo Fernandez1,2, Jiang He1,2, Tanika N Kelly1, Marie Krousel-Wood1,2, Seamus P Whelton3, Owen T Carmichael4, Lydia A Bazzano1,2.   

Abstract

BACKGROUND: Elevated cardiovascular disease risk factor burden is a recognized contributor to poorer cognitive function; however, the physiological mechanisms underlying this association are not well understood. We sought to assess the potential mediation effect of left ventricular (LV) remodeling on the association between lifetime systolic blood pressure and cognitive function in a community-based cohort of middle-aged adults.
METHODS: Nine hundred sixty participants of the Bogalusa Heart Study (59.2% women, 33.8% black, aged 48.4±5.1 years) received 2-dimensional echocardiography to quantify relative wall thickness, LV mass, and diastolic and systolic LV function; and a standardized neurocognitive battery to assess memory, executive functioning, and language processing. Multivariable linear regression assessed the association of cardiac structure and function with a global composite cognitive function score, adjusting for traditional cardiovascular disease risk factors. Mediation analysis assessed the effect of LV mass index on the association between lifetime systolic blood pressure burden and cognitive function.
RESULTS: There were 233 (24.3%) and 136 (14.2%) individuals with concentric LV remodeling and concentric LV hypertrophy, respectively. Each g/m2.7 increment in LV mass index was associated with a 0.03 standardized unit decrement in global cognitive function (P=0.03). Individuals with concentric LV remodeling and isolated diastolic dysfunction had the poorest cognitive function, and a greater ratio between early mitral inflow velocity and early diastolic mitral annular velocity (E/e') was associated with poorer cognitive function, even after adjustment for LV mass index (B=-0.12; P=0.03). A total of 18.8% of the association between lifetime systolic blood pressure burden and midlife cognitive function was accounted for by LV mass index.
CONCLUSIONS: Cardiac remodeling partially mediates the association between lifespan systolic blood pressure burden and adult cognition in individuals without dementia or clinical cardiovascular disease. Slowing or reversing the progression of cardiac remodeling in middle-age may be a novel therapeutic approach to prevent cognitive decline.

Entities:  

Keywords:  dementia; echocardiography; epidemiology; hypertension; ventricular remodeling

Mesh:

Year:  2020        PMID: 32772573      PMCID: PMC7428065          DOI: 10.1161/CIRCIMAGING.119.010335

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  35 in total

1.  Cognitive and brain changes associated with ischaemic heart disease and heart failure.

Authors:  Osvaldo P Almeida; Griselda J Garrido; Christopher Beer; Nicola T Lautenschlager; Leonard Arnolda; Leon Flicker
Journal:  Eur Heart J       Date:  2012-01-31       Impact factor: 29.983

Review 2.  Hypertension and the Brain: A Risk Factor for More Than Heart Disease.

Authors:  Anja Meissner
Journal:  Cerebrovasc Dis       Date:  2016-05-14       Impact factor: 2.762

3.  Dementia from Alzheimer disease and mixed pathologies in the oldest old.

Authors:  Bryan D James; David A Bennett; Patricia A Boyle; Sue Leurgans; Julie A Schneider
Journal:  JAMA       Date:  2012-05-02       Impact factor: 56.272

4.  Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study.

Authors:  Rebecca F Gottesman; Andrea L C Schneider; Marilyn Albert; Alvaro Alonso; Karen Bandeen-Roche; Laura Coker; Josef Coresh; David Knopman; Melinda C Power; Andreea Rawlings; A Richey Sharrett; Lisa M Wruck; Thomas H Mosley
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

5.  Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study.

Authors:  Giovanni de Simone; Jorge R Kizer; Marcello Chinali; Mary J Roman; Jonathan N Bella; Lyle G Best; Elisa T Lee; Richard B Devereux
Journal:  Am J Hypertens       Date:  2005-02       Impact factor: 2.689

6.  Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease.

Authors:  Anne Joutel; Marie Monet-Leprêtre; Claudia Gosele; Céline Baron-Menguy; Annette Hammes; Sabine Schmidt; Barbara Lemaire-Carrette; Valérie Domenga; Andreas Schedl; Pierre Lacombe; Norbert Hubner
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

7.  Associations Between Left Ventricular Dysfunction and Brain Structure and Function: Findings From the SABRE (Southall and Brent Revisited) Study.

Authors:  Chloe M Park; Emily D Williams; Nish Chaturvedi; Therese Tillin; Robert J Stewart; Marcus Richards; Dean Shibata; Jamil Mayet; Alun D Hughes
Journal:  J Am Heart Assoc       Date:  2017-04-18       Impact factor: 5.501

8.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2018-11-26       Impact factor: 44.182

9.  The Burden of Cardiovascular Diseases Among US States, 1990-2016.

Authors:  Gregory A Roth; Catherine O Johnson; Kalkidan Hassen Abate; Foad Abd-Allah; Muktar Ahmed; Khurshid Alam; Tahiya Alam; Nelson Alvis-Guzman; Hossein Ansari; Johan Ärnlöv; Tesfay Mehari Atey; Ashish Awasthi; Tadesse Awoke; Aleksandra Barac; Till Bärnighausen; Neeraj Bedi; Derrick Bennett; Isabela Bensenor; Sibhatu Biadgilign; Carlos Castañeda-Orjuela; Ferrán Catalá-López; Kairat Davletov; Samath Dharmaratne; Eric L Ding; Manisha Dubey; Emerito Jose Aquino Faraon; Talha Farid; Maryam S Farvid; Valery Feigin; João Fernandes; Joseph Frostad; Alemseged Gebru; Johanna M Geleijnse; Philimon Nyakauru Gona; Max Griswold; Gessessew Bugssa Hailu; Graeme J Hankey; Hamid Yimam Hassen; Rasmus Havmoeller; Simon Hay; Susan R Heckbert; Caleb Mackay Salpeter Irvine; Spencer Lewis James; Dube Jara; Amir Kasaeian; Abdur Rahman Khan; Sahil Khera; Abdullah T Khoja; Jagdish Khubchandani; Daniel Kim; Dhaval Kolte; Dharmesh Lal; Anders Larsson; Shai Linn; Paulo A Lotufo; Hassan Magdy Abd El Razek; Mohsen Mazidi; Toni Meier; Walter Mendoza; George A Mensah; Atte Meretoja; Haftay Berhane Mezgebe; Erkin Mirrakhimov; Shafiu Mohammed; Andrew Edward Moran; Grant Nguyen; Minh Nguyen; Kanyin Liane Ong; Mayowa Owolabi; Martin Pletcher; Farshad Pourmalek; Caroline A Purcell; Mostafa Qorbani; Mahfuzar Rahman; Rajesh Kumar Rai; Usha Ram; Marissa Bettay Reitsma; Andre M N Renzaho; Maria Jesus Rios-Blancas; Saeid Safiri; Joshua A Salomon; Benn Sartorius; Sadaf Ghajarieh Sepanlou; Masood Ali Shaikh; Diego Silva; Saverio Stranges; Rafael Tabarés-Seisdedos; Niguse Tadele Atnafu; J S Thakur; Roman Topor-Madry; Thomas Truelsen; E Murat Tuzcu; Stefanos Tyrovolas; Kingsley Nnanna Ukwaja; Tommi Vasankari; Vasiliy Vlassov; Stein Emil Vollset; Tolassa Wakayo; Robert Weintraub; Charles Wolfe; Abdulhalik Workicho; Gelin Xu; Simon Yadgir; Yuichiro Yano; Paul Yip; Naohiro Yonemoto; Mustafa Younis; Chuanhua Yu; Zoubida Zaidi; Maysaa El Sayed Zaki; Ben Zipkin; Ashkan Afshin; Emmanuela Gakidou; Stephen S Lim; Ali H Mokdad; Mohsen Naghavi; Theo Vos; Christopher J L Murray
Journal:  JAMA Cardiol       Date:  2018-05-01       Impact factor: 14.676

10.  Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2018-10-01       Impact factor: 44.182

View more
  2 in total

1.  Au et al. Respond to "Body Mass Index and Risk of Dementia".

Authors:  Rhoda Au; Jinlei Li; Chunyu Liu
Journal:  Am J Epidemiol       Date:  2021-12-01       Impact factor: 4.897

2.  Differential restoration of functional hyperemia by antihypertensive drug classes in hypertension-related cerebral small vessel disease.

Authors:  Masayo Koide; Osama F Harraz; Fabrice Dabertrand; Thomas A Longden; Hannah R Ferris; George C Wellman; David C Hill-Eubanks; Adam S Greenstein; Mark T Nelson
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.